chr17-45983659-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001377265.1(MAPT):​c.1080C>T​(p.Asp360Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.119 in 1,613,920 control chromosomes in the GnomAD database, including 12,181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 976 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11205 hom. )

Consequence

MAPT
NM_001377265.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -4.11

Publications

25 publications found
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]
MAPT Gene-Disease associations (from GenCC):
  • Pick disease
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • semantic dementia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • supranuclear palsy, progressive, 1
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • progressive supranuclear palsy-parkinsonism syndrome
    Inheritance: AR Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 17-45983659-C-T is Benign according to our data. Variant chr17-45983659-C-T is described in ClinVar as Benign. ClinVar VariationId is 98199.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.189 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAPTNM_001377265.1 linkc.1080C>T p.Asp360Asp synonymous_variant Exon 5 of 13 ENST00000262410.10 NP_001364194.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAPTENST00000262410.10 linkc.1080C>T p.Asp360Asp synonymous_variant Exon 5 of 13 1 NM_001377265.1 ENSP00000262410.6 A0A7I2PJZ2

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16238
AN:
152122
Hom.:
973
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0455
Gnomad AMI
AF:
0.0581
Gnomad AMR
AF:
0.147
Gnomad ASJ
AF:
0.105
Gnomad EAS
AF:
0.199
Gnomad SAS
AF:
0.0845
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.121
Gnomad OTH
AF:
0.0994
GnomAD2 exomes
AF:
0.128
AC:
32151
AN:
250932
AF XY:
0.124
show subpopulations
Gnomad AFR exome
AF:
0.0397
Gnomad AMR exome
AF:
0.198
Gnomad ASJ exome
AF:
0.0912
Gnomad EAS exome
AF:
0.209
Gnomad FIN exome
AF:
0.164
Gnomad NFE exome
AF:
0.119
Gnomad OTH exome
AF:
0.125
GnomAD4 exome
AF:
0.120
AC:
175487
AN:
1461680
Hom.:
11205
Cov.:
49
AF XY:
0.119
AC XY:
86526
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.0379
AC:
1270
AN:
33480
American (AMR)
AF:
0.193
AC:
8639
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0948
AC:
2477
AN:
26132
East Asian (EAS)
AF:
0.173
AC:
6878
AN:
39700
South Asian (SAS)
AF:
0.0754
AC:
6504
AN:
86256
European-Finnish (FIN)
AF:
0.164
AC:
8744
AN:
53272
Middle Eastern (MID)
AF:
0.0747
AC:
431
AN:
5768
European-Non Finnish (NFE)
AF:
0.120
AC:
133493
AN:
1111962
Other (OTH)
AF:
0.117
AC:
7051
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
9994
19988
29982
39976
49970
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4904
9808
14712
19616
24520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.107
AC:
16246
AN:
152240
Hom.:
976
Cov.:
33
AF XY:
0.109
AC XY:
8140
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0455
AC:
1890
AN:
41574
American (AMR)
AF:
0.148
AC:
2265
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
365
AN:
3470
East Asian (EAS)
AF:
0.199
AC:
1026
AN:
5148
South Asian (SAS)
AF:
0.0848
AC:
409
AN:
4824
European-Finnish (FIN)
AF:
0.164
AC:
1743
AN:
10596
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.121
AC:
8256
AN:
67998
Other (OTH)
AF:
0.0989
AC:
209
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
758
1515
2273
3030
3788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0985
Hom.:
450
Bravo
AF:
0.104
Asia WGS
AF:
0.167
AC:
577
AN:
3478
EpiCase
AF:
0.115
EpiControl
AF:
0.113

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
VIB Department of Molecular Genetics, University of Antwerp
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Frontotemporal dementia Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.51
DANN
Benign
0.49
PhyloP100
-4.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs63750222; hg19: chr17-44061025; COSMIC: COSV52240701; COSMIC: COSV52240701; API